Authors/Disclosures
|
Luanne Metz, MD
(Foothills Hospital)
|
The institution of Dr. Metz has received research support from Multiple Sclerosis Society of Canada. The institution of Dr. Metz has received research support from Calgary Health Trust. The institution of Dr. Metz has received research support from Government of Alberta. |
|
|
No disclosure on file |
|
|
No disclosure on file |
|
Anthony Traboulsee, MD
(University of British Columbia)
|
Dr. Traboulsee has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Traboulsee has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Traboulsee has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Traboulsee has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Traboulsee has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for EMD Serono. Dr. Traboulsee has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Roche. The institution of Dr. Traboulsee has received research support from Roche. The institution of Dr. Traboulsee has received research support from Genzyme. The institution of Dr. Traboulsee has received research support from Consortium of MS Centers. The institution of Dr. Traboulsee has received research support from MS Canada. Dr. Traboulsee has received personal compensation in the range of $500-$4,999 for serving as a Workshop Chair with Consortium of MS Centers. |
|
Mary L. Myles, MD
|
No disclosure on file |
|
Pierre Duquette, MD
|
The institution of Dr. Duquette has received research support from Biogen and Genzyme. |
|
Jean Godin, MD, MBA
(Novartis Pharmaceuticals Canada Inc.)
|
No disclosure on file |
|
Michel Constantin
|
No disclosure on file |
|
|
No disclosure on file |
|
Reversa R. Mills-Joseph, MD
(Chalmers P Wylie VA)
|
Dr. Mills has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Kyowa Kirin, Inc. Dr. Mills has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Abbvie. |